A trial participant who’d received the shot in Jan. 2023 later developed motor neuropathy, or muscle weakness, leading the ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

amyotrophic lateral sclerosis (ALS). The latter condition – also known as Lou Gehrig’s disease – causes damage to the nerve ...

Advancement of Fast Skeletal Muscle Troponin Activator Expands Pipeline of Muscle-Directed Drug Candidates SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Na ...

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...

Neurological examination revealed distal muscle weakness, areflexia, and sensory impairment in a symmetrical pattern, with ...

It took two years to receive an ALS diagnosis. ALS is a nervous system disease that can cause loss of muscle control and ...

The funds will help local families who are personally impacted by the disease. ALS attacks the nervous system and its nerve ...